SCHEMBL25759296

SCHEMBL25759296

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc(-c5ccc6cc(-c7c8ccccc8c(-c8ccc(-c9cccnc9)cc8)c8ccccc78)ccc6c5)c5ccccc45)cc3)c3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 9/20 0.56
CYP11B2 P19099 9/20 0.56
CYP19A1 P11511 6/20 0.56
CYP17A1 P05093 4/20 0.56
DHODH Q02127 1/20 0.45
PIK3CA P42336 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
GPR84 Q9NQS5 1/20 0.42
CYP2A6 P11509 2/20 0.42
TDO2 P48775 1/20 0.42
MKNK2 Q9HBH9 2/20 0.42
MKNK1 Q9BUB5 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
DYRK3 O43781 1/20 0.41
JAK2 O60674 1/20 0.41
ROCK2 O75116 1/20 0.41
PRKD3 O94806 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032431 0.90 CYP11B2 (0.70) CYP11B1CYP11B2CYP19A1CYP17A1NPC1
SCHEMBL10032221 0.88 CYP11B2 (0.73) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL24433134 0.87 CYP11B1 (0.58) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL10016745 0.87 CYP2A6 (0.48) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL10017211 0.86 CYP11B2 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL13015741 0.85 CYP11B2 (0.68) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL15977618 0.85 CYP11B2 (0.68) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL10016744 0.84 CYP11B1 (0.62) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL13016102 0.84 CYP11B2 (0.67) CYP11B1CYP11B2CYP19A1CYP17A1DHODH
SCHEMBL19825254 0.83 CYP2A6 (0.60) CYP11B1CYP11B2CYP19A1CYP17A1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP1B1 CYP11B1 240/4885CYP11B2 245/4885CYP19A1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.